pentostatin and Anemia--Refractory

pentostatin has been researched along with Anemia--Refractory* in 1 studies

Other Studies

1 other study(ies) available for pentostatin and Anemia--Refractory

Article	Year
Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia. Clinical and laboratory haematology, 1998, Volume: 20, Issue:3 Myelodysplastic syndromes (MDS) have rarely been reported after treatment with nucleoside analogues, and mainly in patients who have also received alkylating agents. We report a patient who developed MDS (refractory anaemia with ring sideroblasts) after treatment with pentostatin (deoxycoformycin) alone. Topics: Adenosine Deaminase Inhibitors; Aged; Anemia, Refractory; Antibiotics, Antineoplastic; Blood Transfusion; Bone Marrow; Combined Modality Therapy; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Hairy Cell; Male; Neutropenia; Pentostatin; Remission Induction	1998

Article

Year

Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia.

Clinical and laboratory haematology, 1998, Volume: 20, Issue:3

Myelodysplastic syndromes (MDS) have rarely been reported after treatment with nucleoside analogues, and mainly in patients who have also received alkylating agents. We report a patient who developed MDS (refractory anaemia with ring sideroblasts) after treatment with pentostatin (deoxycoformycin) alone.

Topics: Adenosine Deaminase Inhibitors; Aged; Anemia, Refractory; Antibiotics, Antineoplastic; Blood Transfusion; Bone Marrow; Combined Modality Therapy; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Hairy Cell; Male; Neutropenia; Pentostatin; Remission Induction

1998